You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Casodex monotherapy

Showing 1 - 25 of 3,453
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cognitive Functioning and Functional Status in Prostate Cancer

Active, not recruiting
  • Prostate Cancer
  • Questionaires
  • fMRI scan (optional)
  • Duarte, California
  • +1 more
Mar 18, 2022

Hormone-refractory Prostate Cancer Trial (AMX-500)

Not yet recruiting
  • Hormone-refractory Prostate Cancer
  • (no location specified)
Aug 11, 2023

Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial (ALE.C04, Pembrolizumab)

Not yet recruiting
  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Sep 19, 2023

Relapsed Refractory Multiple Myeloma Trial (REGN5458, Elotuzumab, Pomalidomide)

Not yet recruiting
  • Relapsed Refractory Multiple Myeloma
  • (no location specified)
Feb 6, 2023

B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma Trial in Australia, United States (BGB-16673)

Recruiting
  • B-cell Malignancy
  • +8 more
  • Phoenix, Arizona
  • +14 more
Jan 17, 2023

Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)

Recruiting
  • Metastatic Breast Cancer
  • +3 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 26, 2023

Gout, Hyperuricemia Trial in United States (dontinurad, dotinurad + allopurinol, allopurinol)

Recruiting
  • Gout
  • Hyperuricemia
  • Clearwater, Florida
  • +3 more
Sep 20, 2023

Androgenetic Alopecia Trial in Jakarta Pusat (Platelet-Rich Plasma and Topical 5% Minoxidil, Topical 5% Minoxidil)

Active, not recruiting
  • Androgenetic Alopecia
  • Platelet-Rich Plasma and Topical 5% Minoxidil
  • Topical 5% Minoxidil
  • Jakarta Pusat, Greater Jakarta Area, Indonesia
    Dr. Cipto Mangunkusumo National General Hospital
Sep 12, 2023

Acute Coronary Syndrome, CYP2C19 Polymorphism Trial in Nieuwegein (Clopidogrel)

Recruiting
  • Acute Coronary Syndrome
  • CYP2C19 Polymorphism
  • Nieuwegein, Utrecht, Netherlands
    St. Antonius Hospital
Jun 27, 2023

Rheumatoid Arthritis Trial in Worldwide (Placebo to Upadacitinib, Methotrexate, Placebo to Methotrexate)

Completed
Has Results
  • Rheumatoid Arthritis
  • Placebo to Upadacitinib
  • +3 more
  • La Mesa, California
  • +289 more
Dec 1, 2022

Migraine Trial in Dhaka (Topiramate 25Mg Tab, Amitriptyline 25 Mg Oral Tablet, topiramate 25mg plus amitriptyline 25mg)

Enrolling by invitation
  • Migraine
  • Topiramate 25Mg Tab
  • +2 more
  • Dhaka, Bangladesh
    Dhaka Medical College
Feb 26, 2023

Cancer in Patients on Dapagliflozin and Other Antidiabetic

Recruiting
  • Breast Cancer
  • Bladder Cancer
    • Wilmington, Delaware
    • +3 more
    Jan 13, 2023

    Advanced Solid Tumors Trial (AMG 355, Pembrolizumab)

    Not yet recruiting
    • Advanced Solid Tumors
    • (no location specified)
    Nov 9, 2023

    Relapsing Forms of Multiple Sclerosis Trial (BIIB091, DRF, Placebo)

    Not yet recruiting
    • Relapsing Forms of Multiple Sclerosis
    • (no location specified)
    Mar 23, 2023

    Melanoma, Melanoma (Skin), Melanoma Stage III Trial in Belarus, India, Russian Federation (BCD-217, BCD-100, Placebo)

    Recruiting
    • Melanoma
    • +6 more
    • BCD-217
    • +2 more
    • Babruysk, Belarus
    • +62 more
    Feb 8, 2023

    Rheumatoid Arthritis Trial in Dhaka (Baricitinib 2 MG, Methotrexate 25mg)

    Recruiting
    • Rheumatoid Arthritis
    • Baricitinib 2 MG
    • Methotrexate 25mg
    • Dhaka, Bangladesh
      Dr. Md. Abu Shahin
    Apr 12, 2023

    Relapsed/Refractory Peripheral T-cell Lymphoma, Relapsed/Refractory Classical Hodgkins Lymphoma Trial in Worldwide (AZD4573)

    Recruiting
    • Relapsed/Refractory Peripheral T-cell Lymphoma
    • Relapsed/Refractory Classical Hodgkins Lymphoma
    • Duarte, California
    • +33 more
    Jan 5, 2023

    Breast Cancer Trial in Chuo-Ku, Kashiwa-Shi, Nagoya-Shi (Amcenestrant (SAR439859))

    Active, not recruiting
    • Breast Cancer
    • Amcenestrant (SAR439859)
    • Chuo-Ku, Japan
    • +2 more
    Nov 16, 2022

    Mantle Cell Lymphoma Trial in China (400mg of TQB3909 tablets, 600mg of TQB3909 tablets)

    Recruiting
    • Mantle Cell Lymphoma
    • 400mg of TQB3909 tablets
    • 600mg of TQB3909 tablets
    • Beijing, Beijing, China
    • +27 more
    Oct 26, 2023

    Androgenetic Alopecia Trial in Jakarta (Minoxidil 5% Topical Solution, microneedling)

    Recruiting
    • Androgenetic Alopecia
    • Minoxidil 5% Topical Solution
    • microneedling
    • Jakarta, DKI Jakarta, Indonesia
      Cipto Mangungkusumo Hospital
    Aug 3, 2023

    B-cell Acute Lymphoblastic Leukemia (B-ALL) Trial in Worldwide (AZD0486)

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia (B-ALL)
    • Duarte, California
    • +30 more
    Nov 13, 2023

    Relapsed/Refractory Multiple Myeloma Trial in Worldwide (AMG 701, Pomalidomide, Dexamethasone)

    Active, not recruiting
    • Relapsed/Refractory Multiple Myeloma
    • AMG 701
    • +2 more
    • Scottsdale, Arizona
    • +33 more
    Nov 29, 2022

    Acne, Healthy Trial in Boston (Altreno, Benzoyl peroxide)

    Active, not recruiting
    • Acne
    • Healthy
    • Boston, Massachusetts
      Beth Israel Deacones Medical Center
    Dec 14, 2022

    Arthritis, Rheumatoid Trial in Upland, Plantation, Mesquite (Placebo, Nipocalimab, Certolizumab)

    Recruiting
    • Arthritis, Rheumatoid
    • Placebo
    • +2 more
    • Upland, California
    • +2 more
    Sep 1, 2023

    Alopecia Areata Trial (NXC736, Placebo)

    Not yet recruiting
    • Alopecia Areata
    • (no location specified)
    Oct 23, 2023